30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Broom Colin MD

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -68%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Broom Colin MD's trades of Nabriva Therapeutics PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-04 2022-08-02
S Sale
95,246 -20.3%
230.19
US$3,102,342 		95,246 -20.3% 230.19 US$3,102,342
2020-08-21 2020-08-20
S Sale
63,774 -10.8%
42.11
US$3,957,848 		63,774 -10.8% 42.11 US$3,957,848
2019-09-03 2019-08-30
B Purchase
90,130 +42.3%
66.52
US$4,440,583 		90,130 +42.3% 66.52 US$4,440,583